查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1620368

阿奇霉素的全球市场规模:各类型，各流通管道，各地区，范围及预测

Global Azithromycin Market Size By Type (Oral, Injectable, and Ophthalmic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

阿奇霉素市场规模及预测

2024年阿奇霉素市场规模为69.8亿美元，预计到2031年将达到107.1亿美元，2024年至2031年复合年增长率为3.5%。细菌感染盛行率的增加正在推动阿奇霉素市场的成长。阿奇霉素全球市场报告提供了对市场的整体评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

全球阿奇霉素市场的定义

阿奇霉素是属于抗菌抗生素的一类药物。一种有助于治疗细菌感染的抗生素。阿奇霉素通常以 Zithromax 或 Zmax 的名称出售。在这些情况下，医生可能会开立阿奇霉素来治疗肺部、鼻窦、皮肤和其他身体部位的轻度至中度感染。它可以抵抗有害微生物的生长，并且可以对抗多种微生物，包括真桿菌科的一些微生物。

它是世界上最受欢迎的抗生素之一。它是世界上最受欢迎的抗生素之一。阿奇霉素注射剂用于治疗结合细菌感染，如呼吸道疾病、肺炎或耳部感染。

阿奇霉素可能是源自片霉素的大环内酯类抗生素。阿奇霉素的作用是与微生物核醣体亚基结合，抑制大分子合成的易位步骤，并抑制细菌生长。用于治疗呼吸道疾病、肺炎、性传染病等微生物引起的感染及皮肤、耳朵的不同感染及不同代谢感染。它也用于治疗真正的鸟细菌晚期 (MAC) 感染。

细菌感染盛行率不断上升，因此阿奇霉素片剂作为仿製药和名药的便利性日益增加，是可能推动市场成长的主要因素。此外，趋势支出的增加、阿奇霉素作为预防药物的重要性的增加以及製药公司为加速分析活动而增加的投资都是推动阿奇霉素市场扩张的因素。

阿奇霉素全球市场概况

细菌感染盛行率的增加正在推动阿奇霉素市场的扩张。阿奇霉素是世界上最受欢迎的抗生素。阿奇霉素非常经济，并且已被证明比其他类似产品在身体组织中的保留时间更长。在阿奇霉素市场，各公司正在积极投资和研究新疗法和新市场空白。

新冠肺炎 (COVID-19) 已触及抗生素市场，并扰乱了全球处方药输送链。然而，一些抗生素最初用于治疗 COVID-19，并被广泛用于治疗 COVID-19 的处方和研究。例如，2020 年 3 月，辉瑞公司公布了在法国进行的冠状病毒 (COVID-19) 超标试验中滥用其阿奇霉素 (Zithromax) 药物和 Plaquenil 的积极讯息。在 COVID-19大流行期间，对抗生素的需求庞大，这对抗生素研究市场产生了重大影响。

例如，抗生素已被批准用于预防爱滋病毒感染者的细菌感染。然而，在一段时间内，由于相关风险问题，监管机构对许多治疗方法的否决限制了阿奇霉素市场的扩张。目前，阿奇霉素用于治疗急性细菌性泌尿道感染、性溃疡病、鼻窦炎、慢性阻塞性肺病细菌性加重、社区获得性呼吸道疾病、咽炎、皮肤感染以及各种症状。

如上所述，新兴市场对阿奇霉素的需求正在显着成长。中国、印度、巴西和墨西哥等新兴市场对阿奇霉素的需求正在快速成长。这为在这个市场阶段运作的药品製造商提供了巨大的机会。

然而，长期服用阿奇霉素导致抗药性细菌发生率增加，以及与阿奇霉素相关的副作用，如噁心、腹痛、腹泻、心律不整、严重头晕和眼部问题，是抑制市场的因素增长，是预测期内阿奇霉素市场的进一步挑战。

目录

第1章 阿奇霉素的全球市场:简介

  • 市场概要
  • 调查范围
  • 前提条件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的调查手法

  • 资料探勘
  • 检验
  • 主要采访
  • 资料来源一览

第4章 阿奇霉素的全球市场展望

  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力分析模式
  • 价值链分析

第5章 阿奇霉素的全球市场:各类型

  • 概要
  • 口服剂
  • 注射剂
  • 其他

第6章 阿奇霉素的全球市场:各流通管道

  • 概要
  • 医院药局
  • 零售药局
  • 其他

第7章 阿奇霉素的全球市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区
    • 南美
    • 中东·非洲

第8章 全球阿奇霉素市场:竞争情形

  • 概要
  • 各公司的市场排行榜
  • 主要的开发策略

第9章 企业简介

  • CSPC Ouyi Pharmaceutical
  • Aurobindo Pharma
  • Gland Pharma
  • Wockhardt
  • Sandoz
  • Zydus Pharmaceuticals
  • Mylan
  • Teva
  • Akorn
  • Pfizer

第10章 相关调查

简介目录
Product Code: 11630

Azithromycin Market Size And Forecast

Azithromycin Market size was valued at USD 6.98 Billion in 2024 and is projected to reach USD 10.71 Billion by 2031 , growing at a CAGR of 3.5% from 2024 to 2031. The increasing prevalence of bacterial infection is driving the growth of the Azithromycin Market. The Global Azithromycin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Azithromycin Market Definition

Azithromycin is a class of drugs, that belongs to antibacterials antibiotics. It is an antibiotic that helps in treating bacterial infections. It is normally sold beneath the whole names Zithromax and Zmax. A doctor might impose azithromycin to treat mild-to-moderate infections of the lungs, sinuses, skin, and different body elements. It will resist harmful microorganisms from growing and may fight a large variety of microorganisms, together with several within the eubacteria family.

Azithromycin may be a macrolide antibiotic used to treat bacterial infections. it's one of the world's most popular antibiotics. The injectable sort of azithromycin is employed to treat bound bacterial infections, like respiratory disease, pneumonia, or ear infections. injectable azithromycin is typically given as an infusion into a vein over 60 minutes.

Azithromycin may be a macrolide antibiotic that's derived from Pediamycin. It works by inhibiting the translocation step in macromolecule synthesis by binding to ribosomal subunits in microorganisms which ends with the inhibition of bacterial growth. It is used for the treatment of infections caused by microorganisms like respiratory disease, pneumonia, sexually transmitted diseases, and different infection of the attention, skin, ear, and different metabolism infections. It can be conjointly utilized in the treatment of true bacteria avium advanced (MAC) infection.

The rise in the prevalence of bacterial infections, and therefore the increasing handiness of azithromycin tablets as generic and name medicine are the key factors that may drive the market growth. Also, growing tending expenditure, increasing importance of azithromycin as a prophylactic agent, and an increase in the investment by pharmaceutical corporations to accelerate analysis activities are the factors that may expand the Azithromycin Market.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Azithromycin Market Overview

The increasing prevalence of bacterial infection is driving the expansion of the Azithromycin Market. Azithromycin is the world's most popular antibiotic. It is verified to be extraordinarily economical and capable of remaining within the body tissue longer than other similar varieties. Companies are investing and investigating considerably within the Azithromycin marketplace for a new treatment, gap due to new markets.

COVID-19 wedged the worldwide offer chain of prescription drugs, touching the antibiotics market. However, several antibiotics were at first used to treat COVID-19 and are widely prescribed and studied because of the COVID-19 remedy. For instance, in March 2020, Pfizer declared positive information for exploitation of its azithromycin (Zithromax) drug, together with Plaquenil, in an exceeding coronavirus (COVID-19) test performed in France. There was a large demand for antibiotics throughout the COVID-19 pandemic, that conjointly wedged the studied market of antibiotics.

For instance, authority approval for preventing bacterial infections in individuals with HIV. However, at constant times, authority disapproval for many therapies due to risk issues associated is restraining the expansion of the Azithromycin Market. At present, azithromycin is approved for acute bacterial urinary tract infection, venereal ulceration malady, sinusitis, bacterial exacerbations of chronic clogging pneumonic malady community-acquired respiratory disease, sore throat, skin infections, and different conditions.

There is a huge and growing demand from rising markets. The demand for azithromycin is growing quickly in rising markets like China, India, Brazil, and Mexico due to the increasing incidence of infectious diseases as well as rising incomes and increasing tending infrastructure. This presents a large chance for drugmakers in operation during this market phase.

However, an increase in the incidence of bacterial resistance due to long-run administration of azithromycin and the effects related to azithromycins like nausea, abdominal pain, diarrhea, irregular heartbeat, severe lightheadedness, and eye issues are the factors that may hinder the market growth and an additional challenge the Azithromycin Market within the forecast period.

Global Azithromycin Market Segmentation Analysis

The Global Azithromycin Market is segmented on the basis of Type, Distribution Channel, And Geography.

Azithromycin Market, By Type

  • Oral
  • Injectable
  • Ophthalmic

Based on Type, the market is segmented into Oral, Injectable, and Ophthalmic. The Oral segment is dominating the market with the highest market share and is expected to grow substantially and dominate the global market during the forecast period.

Azithromycin Market, By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The Hospital Pharmacies component is witnessing the highest market share with strong market growth during the forecast period in the global market. The Segment centers on the standing and opportunity for significant application value, market share, and growth valuation of each application.

Azithromycin Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on Regional Analysis, the Global Azithromycin Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North America and Europe regions are dominating the Global Market with the highest market stake and are predicted to grow substantially and dominate the Global Azithromycin Market throughout the forecast period.

Key Players

  • The "Global Azithromycin Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Pfizer, Akorn, Teva, Mylan, Zydus Pharmaceuticals, Sandoz, Wockhardt, Gland Pharma, Aurobindo Pharma, and CSPC Ouyi Pharmaceutical, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation, Anke Hengyi
  • . Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL AZITHROMYCIN MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL AZITHROMYCIN MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porter Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL AZITHROMYCIN MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Oral
  • 5.3 Injectable
  • 5.4 Others

6 GLOBAL AZITHROMYCIN MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
  • 6.2 Hospital Pharmacies
  • 6.3 Retail Pharmacies
  • 6.4 Others

7 GLOBAL AZITHROMYCIN MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 The U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 The U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 The Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 The Middle East and Africa

8 GLOBAL AZITHROMYCIN MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 CSPC Ouyi Pharmaceutical
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Aurobindo Pharma
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Gland Pharma
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Wockhardt
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Sandoz
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Zydus Pharmaceuticals
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Mylan
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Teva
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Akorn
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Pfizer
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Related Research